Dao-Cheng Wu

Integrative genetic and transcriptomic analyses prioritize CDC16 as a candidate marker for gastric cancer.

Convergent genetic, transcriptomic, and protein-level evidence prioritizes CDC16 as a GC-associated candidate tissue marker whose expression is closely linked to proliferative activity.